PROTECTIVE ACTIONS OF TAMOXIFEN AND 4-HYDROXYTAMOXIFEN AGAINST OXIDATIVE DAMAGE TO HUMAN LOW-DENSITY LIPOPROTEINS - A MECHANISM ACCOUNTING FOR THE CARDIOPROTECTIVE ACTION OF TAMOXIFEN

被引:71
作者
WISEMAN, H [1 ]
PAGANGA, G [1 ]
RICEEVANS, C [1 ]
HALLIWELL, B [1 ]
机构
[1] UNITED MED SCH GUYS & ST THOMASS HOSP, GUYS HOSP, DIV BIOCHEM, LONDON SE1 9RT, ENGLAND
关键词
D O I
10.1042/bj2920635
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Tamoxifen and 4-hydroxytamoxifen protect isolated human low-density lipoproteins (LDLs) against copper-ion-dependent lipid peroxidation: 4-hydroxytamoxifen is more protective than tamoxifen or 17beta-oestradiol. 4-Hydroxytamoxifen and 17beta-oestradiol also prevent the increase in the electrophoretic mobility of LDL caused by exposure to copper ions, presumably by protection of the apoprotein B of LDL against oxidative modification. Our observations may help to account for the cardioprotective benefits reported to be associated with tamoxifen therapy and prophylaxis in breast cancer.
引用
收藏
页码:635 / 638
页数:4
相关论文
共 35 条
[1]   RESULTS OF THE CANCER-RESEARCH CAMPAIGN ADJUVANT TRIAL FOR PERIOPERATIVE CYCLOPHOSPHAMIDE AND LONG-TERM TAMOXIFEN IN EARLY BREAST-CANCER REPORTED AT THE 10TH YEAR OF FOLLOW-UP [J].
BAUM, M ;
HOUGHTON, J ;
RILEY, D ;
MACINTYRE, J ;
BERSTOCK, D ;
MCKINNA, A ;
JACKSON, I ;
SAINSBURY, JRC ;
WILSON, A ;
WHEELER, T ;
DOBBS, J ;
REES, G ;
POWLES, T ;
RUBENS, R ;
HAYBRITTLE, J ;
MCPHERSON, K ;
HOUGHTON, J .
ACTA ONCOLOGICA, 1992, 31 (02) :251-257
[2]   PROSPECTS FOR THE PRIMARY PREVENTION OF BREAST-CANCER [J].
BERNSTEIN, L ;
ROSS, RK ;
HENDERSON, BE .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1992, 135 (02) :142-152
[3]  
BUTTA A, 1992, CANCER RES, V52, P4261
[4]  
CHUNG BH, 1980, J LIPID RES, V21, P284
[5]   LONG-TERM EFFECTS OF TAMOXIFEN ON BLOOD LIPID VALUES IN BREAST-CANCER [J].
DEWAR, JA ;
HOROBIN, JM ;
PREECE, PE ;
TAVENDALE, R ;
TUNSTALLPEDOE, H ;
WOOD, RAB .
BRITISH MEDICAL JOURNAL, 1992, 305 (6847) :225-226
[6]   THE ROLE OF LIPID-PEROXIDATION AND ANTIOXIDANTS IN OXIDATIVE MODIFICATION OF LDL [J].
ESTERBAUER, H ;
GEBICKI, J ;
PUHL, H ;
JURGENS, G .
FREE RADICAL BIOLOGY AND MEDICINE, 1992, 13 (04) :341-390
[7]   CONTINUOUS MONITORING OF INVITRO OXIDATION OF HUMAN LOW-DENSITY LIPOPROTEIN [J].
ESTERBAUER, H ;
STRIEGL, G ;
PUHL, H ;
ROTHENEDER, M .
FREE RADICAL RESEARCH COMMUNICATIONS, 1989, 6 (01) :67-75
[8]   PROSPECTIVE CONTROLLED TRIAL WITH ANTIESTROGEN DRUG TAMOXIFEN IN PATIENTS WITH UNRESECTABLE HEPATOCELLULAR-CARCINOMA [J].
FARINATI, F ;
DEMARIA, N ;
FORNASIERO, A ;
SALVAGNINI, M ;
FAGIUOLI, S ;
CHIARAMONTE, M ;
NACCARATO, R .
DIGESTIVE DISEASES AND SCIENCES, 1992, 37 (05) :659-662
[9]  
HAMILTON C, 1992, INTRO NEW TREATMENTS, P315
[10]   EFFECT OF 17 BETA ESTRADIOL ON AORTIC CHOLESTEROL CONTENT AND METABOLISM IN CHOLESTEROL-FED RABBITS [J].
HOUGH, JL ;
ZILVERSMIT, DB .
ARTERIOSCLEROSIS, 1986, 6 (01) :57-63